Endocarditis Prophylaxis - University of Chicago



HYPERTHYROIDISM

Gretchen Berland, M.D.

WEEK 18

Learning Objectives:

1. To know the most common causes of hyperthyroidism

2. To know the laboratory tests used to diagnose hyperthyroidism

3. To be aware of the approach to diagnosis and management of subclinical hyperthyroidism

CASE ONE

Ms. Shaki is a 38-year-old healthy high school drama teacher who presents to your clinic reporting that she “just hasn’t been feeling right.” Over the past six months she reports “feeling tired most of the time” and has lost 15 pounds despite an increased appetite. She also describes some heat intolerance as well as increased perspiration and reports that her skin “feels really smooth.” Her past medical and surgical history is unremarkable, and she reports no personal or family history of thyroid disease. She takes no medications, does not use alcohol or tobacco, and has monthly menstrual periods. On exam, her resting heart rate is 100, her blood pressure is 122/64. Her thyroid feels enlarged, but is non-tender. The rest of her physical exam is unremarkable.

Questions:

1. What might Ms. Shaki have?

In this patient, hyperthyroidism should be suspected given the constellation of symptoms and the physical exam findings. Hyperthyroidism is the clinical expression of a group of disorders that produce an excess of circulating thyroid hormones including free thyroxine (FT4) and/or triiodothyronine (T3). The most common causes of hyperthyroidism include Graves’ disease, followed by toxic multinodular goiter, and solitary functioning nodules (see Table 1, Lancet paper). Autoimmune postpartum and subacute thyroiditis, tumors that secrete thyrotropin, and drug-induced thyroid dysfunction are also important causes.

Graves’ disease is an autoimmune disorder characterized by antibodies in the circulation that are directed against the thyrotropin receptor. It accounts for about 85% of the cases of hyperthyroidism in patients younger than age 40. In most patients with Graves’, the typical symptoms of hyperthyroidism are present. Symptoms include heat intolerance, weight loss, weakness, palpitations, oligomenorrhea and anxiety. Signs include brisk tendon reflexes, fine tremor, proximal weakness, stare and eyelid lag.

Toxic multinodular goiter accounts for most cases of hyperthyroidism in middle-aged and elderly persons. The condition is often associated with a long-standing simple goiter. Cardiac abnormalities may be present including sinus tachycardia, atrial fibrillation and exacerbation of coronary artery disease or heart failure. Lid lag may be noted on occasion but exopthalmos does not occur. In the elderly, hyperthyroidism may present only as weight loss and apathy, so a high index of suspicion is needed to make the diagnosis.

2. What tests would you like to order?

The serum TSH is the best initial diagnostic test, as a TSH level higher than

0.1 uU/ml excludes overt clinical hyperthyroidism.

If the serum TSH is lower than 0.1 uU/ml, plasma free T4 and T3 should be measured. If the serum TSH is low, and free T4 and T3 are high, the diagnosis of hyperthyroidism is confirmed, and a 24-hour thyroid radioiodine uptake scan can be ordered to differentiate Grave’ hyperthyroidism from other causes (see p. 461, Lancet article).

According to Cooper, the 24-hour radioactive iodine uptake (RAI) is a measure of the iodine avidity of the thyroid gland. Uptake will be increased in patients with Graves’ disease, toxic multinodular goiter and toxic adenoma. Uptake will be low in patients with thyroiditis, exogenous hormone intake, extraglandular hormone production and iodide exposure. The radioactive iodine scan is very helpful in distinguishing mild Graves’ disease from painless or postpartum thyroiditis.

CASE ONE CONTINUED:

The laboratory results for Ms. Shaki indicate she has overt hyperthyroidism, her TSH is less than 0.1 uU/ml and her free T4 and T3 are markedly elevated. A 24-hour RAI is elevated. You call her to discuss her results.

3. What do you tell her?

The clinical symptoms and laboratory findings indicate that Ms. Shaki has Graves’ disease. Some forms of hyperthyroidism are transient and require only symptomatic therapy (subacute or postpartum thyroiditis). The three methods available for definitive therapy include: anti-thyroid drugs (thionamides), radioiodine, and subtotal thyroidectomy (see Table 2, Lancet paper). The selection of therapy depends on many factors. In the US, RAI therapy is the treatment of choice for most patients, but cannot be used in pregnancy. Beta-adrenergic antagonists are used to relieve symptoms of hyperthyroidism, including tremor, palpitations, and anxiety. During treatment, patients are followed by clinical evaluation and measurement of T4 (TSH maybe misleading as it may remain low for weeks to months even though the patient is euthyroid and T4 is normal). Thyroid function should be assessed every 4-6 weeks for the first 4-6 months. All patients with Graves’ disease require lifelong follow-up for recurrent hyperthyroidism or development of hypothyroidism.

CASE TWO:

Ms. Fraser is a 74-year-old woman with coronary artery disease, s/p CABG in 2001, hyperlipidemia, and osteoporosis. She reports she is feeling fine, and other than occasionally feeling “tired”, reports no specific complaints. She denies chest pain, dyspnea at rest or with exertion, and has had no recent change in weight. Her medicine list includes aspirin, atenolol, atorvastatin, and alendronate weekly. Her thyroid gland is non-tender on exam, and you think it is somewhat enlarged. Thyroid function tests indicate a TSH concentration lower than 0.1 uU/ml but free T4 and T3 are within the reference ranges. An ultrasound reveals a multinodular goiter.

4. What do you want to do?

Figure 2 on page 241 of the JAMA paper outlines the approach to the diagnosis and management of subclinical hyperthyroidism.

Subclinical hyperthyroidism is defined as a decrease in serum TSH concentration below the reference range with normal serum free T4 and T3 concentrations. Subclinical thyroid disease is a diagnosis based on laboratory evaluation, patients often do not present with any clinical signs or symptoms suggestive of thyroid dysfunction.

According to Col et al, management of patients with thyroid dysfunction remains controversial because the body of scientific evidence needed to guide clinical decision-making is limited. Because untreated subclinical hyperthyroidism with suppressed serum TSH carries the potential risk of atrial fibrillation, cardiovascular mortality and osteoporosis, the balance is shifted towards treatment in older patients.

References:

1. Cooper DS. Hyperthyroidism. Lancet. 2003; 362:459-467.

2. Col, NF, Surks, MI, Daniels, GH. Subclinical thyroid disease. JAMA. 2004;291: 239-243.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download